Prognostic value of ZFP36 and SOCS3 expressions in human prostate cancer

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical and Translational Oncology

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12094-015-1432-6PMID 26563146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• “High-Risk” Prostate Cancer: Classification and Therapy

  2015cited by this paper
• Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.

  2014cited by this paper
• Management of low risk prostate cancer: active surveillance and focal therapy

  2014cited by this paper
• MicroRNA‐224 inhibits progression of human prostate cancer by downregulating TRIB1

  2014cited by this paper
• Management of low risk prostate cancer—active surveillance and focal therapy

  2014cited by this paper
• High-risk prostate cancer—classification and therapy

  2014cited by this paper
• NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer

  2013cited by this paper
• Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein

  2012cited by this paper
• Risk-based prostate cancer screening.

  2012cited by this paper
• Tristetraprolin: roles in cancer and senescence.

  2012cited by this paper
• The role of tristetraprolin in cancer and inflammation.

  2012cited by this paper
• Role of SOCS3 Evaluated by Immunohistochemical Analysis in a Cohort of Patients Affected by Prostate Cancer: Preliminary Results

  2012cited by this paper
• May abnormal carotid intima-media thickness predict colorectal neoplasm?

  2011cited by this paper
• Tristetraprolin downregulates the expression of both VEGF and COX-2 in human colon cancer.

  2011cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.

  2010cited by this paper
• Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma

  2010cited by this paper
• Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia (vol 11, pg 717, 2010)

  2010cited by this paper
• Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia

  2010cited by this paper
• Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer

  2010cited by this paper
• The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis.

  2009cited by this paper
• RNA-destabilizing Factor Tristetraprolin Negatively Regulates NF-κB Signaling*

  2009cited by this paper
• SOCS1 and SOCS3 in the control of CNS immunity.

  2009influential reference
• Tristetraprolin Impairs NF-κB/p65 Nuclear Translocation*

  2009cited by this paper
• miR‐29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis

  2009cited by this paper
• Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors.

  2009cited by this paper
• Autocrine IL-6 signaling: a key event in tumorigenesis?

  2008cited by this paper
• Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.

  2008cited by this paper
• Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

  2007cited by this paper
• Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon

  2007cited by this paper
• Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB.

  2007cited by this paper
• Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.

  2007cited by this paper
• IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.

  2007cited by this paper
• Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.

  2006cited by this paper
• SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition

  2005cited by this paper
• Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma

  2005cited by this paper
• SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

  2003cited by this paper
• SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation

  2003influential reference
• Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.

  2002cited by this paper
• Ureaplasma urealyticum Modulates Endotoxin-Induced Cytokine Release by Human Monocytes Derived from Preterm and Term Newborns and Adults

  2001cited by this paper
• Expression of suppressors of cytokine signaling during liver regeneration.

  2001cited by this paper
• A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency.

  1996cited by this paper
• Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

  1986cited by this paper

• Targeting the "tumor microenvironment": RNA-binding proteins in the spotlight in colorectal cancer therapy.

  2024cites this paper
• Integrative bioinformatics analysis reveals novel insights into osteoarthritis pathogenesis and diagnostic biomarkers

  2024cites this paper
• Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice

  2024cites this paper
• Dysregulated expression of the suppressors of cytokine signaling (SOCS) contributes to the development of prostate cancer.

  2024cites this paper
• Zinc Finger Protein 36 Triggers Proliferation in Renal Cell Carcinoma by Negatively Regulating Krüppel-Like Transcription Factor 10

  2023cites this paper
• Resistin stimulates PC-3 prostate cancer cell growth through stimulation of SOCS3 and SOCS5 genes

  2023cites this paper
• ZFP36 loss-mediated BARX1 stabilization promotes malignant phenotypes by transactivating master oncogenes in NSCLC

  2023cites this paper
• Loss of tristetraprolin activates NF-κB induced phenotypic plasticity and primes transition to lethal prostate cancer

  2023influential citation
• Single-cell transcriptomics reveals cell type diversity of human prostate.

  2022cites this paper
• Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification

  2022cites this paper
• Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients

  2022cites this paper
• ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress

  2022cites this paper
• Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey

  2021cites this paper
• Identification of a novel iron zinc finger protein 36 (ZFP36) for predicting the overall survival of osteosarcoma based on the Gene Expression Omnibus (GEO) database

  2021cites this paper
• LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway

  2021cites this paper
• Tristetraprolin, a Potential Safeguard Against Carcinoma: Role in the Tumor Microenvironment

  2021cites this paper
• The Tristetraprolin Family of RNA-Binding Proteins in Cancer: Progress and Future Prospects

  2020cites this paper
• MiR-221 affects proliferation and apoptosis of gastric cancer cells through targeting SOCS3.

  2019cites this paper
• Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer

  2019cites this paper
• MiR-221 affects cholangiocarcinoma cell proliferation and apoptosis by targeting the SOCS3/JAK-STAT signaling pathway

  2019cites this paper
• Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer

  2018cites this paper